Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,625 | -68,994 | -58,293 | -63,059 | -32,672 |
| Depreciation Amortization | -15,545 | -8,525 | -5,733 | -1,342 | -59 |
| Accounts receivable | N/A | N/A | N/A | N/A | 8,000 |
| Accounts payable and accrued liabilities | 977 | 1,584 | 277 | -294 | 2,139 |
| Other Working Capital | 6,714 | 685 | -6,554 | 4,276 | 8,842 |
| Other Operating Activity | 39,244 | 31,436 | 19,728 | 17,497 | -3,226 |
| Operating Cash Flow | $-82,235 | $-43,814 | $-50,575 | $-42,922 | $-16,976 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -299,938 | -257,662 | -39,344 | 64,711 | -339,481 |
| PPE Investments | -1,043 | -359 | -1,850 | -6,445 | -1,482 |
| Investing Cash Flow | $-300,981 | $-258,021 | $-41,194 | $58,266 | $-340,963 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,945 | 713,235 | 59,548 | 500 | 1,810 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 384,714 |
| Financing Cash Flow | $4,945 | $713,235 | $59,548 | $500 | $386,524 |
| Beginning Cash Position | 431,421 | 20,021 | 52,242 | 36,398 | 7,813 |
| End Cash Position | 53,150 | 431,421 | 20,021 | 52,242 | 36,398 |
| Net Cash Flow | $-378,271 | $411,400 | $-32,221 | $15,844 | $28,585 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,235 | -43,814 | -50,575 | -42,922 | -16,976 |
| Capital Expenditure | -1,043 | -359 | -1,850 | -6,445 | -1,482 |
| Free Cash Flow | -83,278 | -44,173 | -52,425 | -49,367 | -18,458 |